-
公开(公告)号:US20210167743A1
公开(公告)日:2021-06-03
申请号:US16067539
申请日:2017-01-04
Applicant: THE TRUSTEES OF DARTMOUTH COLLEGE
Inventor: Kofi ODAME , Yueh-Ching TENG
Abstract: An amplitude detector has a phase shifter such as one using an analog differentiator and an adjustable gain stage, or one using a determinable delay, the phase shifter coupled to shift phase of an input signal to the amplitude detection apparatus. The detector also has a first analog multiplier coupled to square the input signal, a second analog multiplier coupled to square output of the phase shifter; and an analog adder coupled to sum outputs of the first and second analog multiplier. An automatic gain control circuit has the amplitude detector coupled to control gain of a controllable amplifier.
-
2.
公开(公告)号:US20180199855A1
公开(公告)日:2018-07-19
申请号:US15742510
申请日:2016-07-07
Applicant: THE TRUSTEES OF DARTMOUTH COLLEGE
Inventor: Kofi ODAME , Justice AMOH
CPC classification number: A61B5/0823 , A61B5/0024 , A61B5/087 , A61B5/486 , A61B5/6822 , A61B5/6823 , A61B5/7207 , A61B5/725 , A61B5/7267 , A61B7/003 , A61B2562/0204 , A61B2562/0219 , A61B2562/0247 , A61B2562/0261 , G06F16/22 , G16H10/60
Abstract: A system adapted to assisting patients manage asthma includes a wearable sensor for detection of asthma symptoms and inhaler use, having a microphone capable of generating an electrical signal indicative of asthma symptoms or inhaler use; a processor with firmware adapted to process the electrical signal to determine potential asthma symptoms and inhaler use; and store the electrical signal in the memory when the electrical signal potentially corresponds asthma symptoms or inhaler use. In particular embodiments, the system includes an electronic asthma diary including detected asthma symptoms and detected inhaler usage, both with timestamps, and a prescribed treatment protocol. Protocol firmware processes detected asthma symptoms an inhaler usage recorded in the asthma diary to determine if asthma is controlled, and if asthma is not determined controlled determines if a treatment change is authorized; if treatment change is authorized the treatment change is displayed in human-readable form.
-
公开(公告)号:US20230208373A1
公开(公告)日:2023-06-29
申请号:US18116755
申请日:2023-03-02
Applicant: THE TRUSTEES OF DARTMOUTH COLLEGE
Inventor: Kofi ODAME , Yueh-Ching TENG
CPC classification number: H03G3/3036 , H03F3/24
Abstract: An amplitude detector has a phase shifter such as one using an analog differentiator and an adjustable gain stage, or one using a determinable delay, the phase shifter coupled to shift phase of an input signal to the amplitude detection apparatus. The detector also has a first analog multiplier coupled to square the input signal, a second analog multiplier coupled to square output of the phase shifter; and an analog adder coupled to sum outputs of the first and second analog multiplier. An automatic gain control circuit has the amplitude detector coupled to control gain of a controllable amplifier.
-
公开(公告)号:US20220151509A1
公开(公告)日:2022-05-19
申请号:US17532983
申请日:2021-11-22
Applicant: THE TRUSTEES OF DARTMOUTH COLLEGE
Inventor: Kofi ODAME , Justice AMOH
Abstract: A system adapted to assisting patients manage asthma includes a wearable sensor for detection of asthma symptoms and inhaler use, having a microphone capable of generating an electrical signal indicative of asthma symptoms or inhaler use; a processor with firmware adapted to process the electrical signal to determine potential asthma symptoms and inhaler use; and store the electrical signal in the memory when the electrical signal potentially corresponds asthma symptoms or inhaler use. In particular embodiments, the system includes an electronic asthma diary including detected asthma symptoms and detected inhaler usage, both with timestamps, and a prescribed treatment protocol. Protocol firmware processes detected asthma symptoms an inhaler usage recorded in the asthma diary to determine if asthma is controlled, and if asthma is not determined controlled determines if a treatment change is authorized; if treatment change is authorized the treatment change is displayed in human-readable form.
-
-
-